Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib. [electronic resource]
Producer: 20181211Description: 2149-2161 p. digitalISSN:- 1177-8881
- Animals
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Hepatocellular -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Dose-Response Relationship, Drug
- Doxorubicin -- administration & dosage
- Drug Carriers -- chemistry
- Drug Delivery Systems
- Drug Screening Assays, Antitumor
- Hep G2 Cells
- Humans
- Lipids -- chemistry
- Liver Neoplasms -- drug therapy
- Liver Neoplasms, Experimental -- drug therapy
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Monosaccharides -- chemistry
- Nanoparticles -- chemistry
- Sorafenib -- administration & dosage
- Structure-Activity Relationship
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.